This article is more than 5 years old. Information may no longer be current.
I-Glide corneal graft device receives patents in US, Europe
Click Here to Manage Email Alerts
The I-Glide, a device for preservation and transportation of corneal endothelium, has received patents in the U.S. and Europe, Eurobio announced in a press release.
The device helps to make Descemet’s stripping automated endothelial keratoplasty easier, quicker and more flexible, with a minimal learning curve for the surgeon, the release said. A lamellar membrane is inserted in the I-Glide, which is filled with a storage medium, and the endothelium can then be preserved for up to 1 week.
“These two patents result from a strategic partnership between Eurobio and the [Veneto Eye Bank Foundation]. We are glad and proud to concretize this new offer for a device aimed towards handling and storage of corneal lamellar grafts,” Denis Fortier, general manager of Eurobio, said in the release. “This device also enables us to enhance our commercial offer for the American market.”
The company holds exclusive global marketing rights for the I-Glide device.